Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry

A. Kronseder, M. Truger, S. Peters, S. Karrasch, A.R. Koczulla, D. Nowak, R.A. Jörres (Munich, Germany)

Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Session: COPD monitoring in stable disease and during exacerbation
Session type: Poster Discussion
Number: 3227
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kronseder, M. Truger, S. Peters, S. Karrasch, A.R. Koczulla, D. Nowak, R.A. Jörres (Munich, Germany). Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry. Eur Respir J 2012; 40: Suppl. 56, 3227

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012


The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Liquid chromatography-mass spectrometry (LC/MS) detects biomarker proteins in exhaled breath condensate (EBC) from endotracheally intubated patients collected at the exhaust port of a ventilator
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006

Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008

Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008



High performance liquid chromatography analysis of nitrosothiols and nitrite in exhaled breath condensate in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006

Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS.
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Liquid chromatography/mass spectrometry analysis of leukotriene B4 in exhaled breath condensate in asthmatic children
Source: Eur Respir J 2005; 26: Suppl. 49, 41s
Year: 2005